Scientists at King’s College London have developed an innovative IgE antibody therapy that activates the immune system to ...

Researchers at King's College London have developed IgE antibodies targeting HER2-expressing cancers. Early studies show ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Type I allergy, an IgE antibody triggered hypersensitivity disease, represents a common public health problem affecting about one third of the world´s population. Upon exposure to allergens, IgE ...

However, this treatment is not always effective in some patients. Now scientists have investigated a different antibody type, IgE, which activates the patient's immune system in different ways to IgG.

A team of scientists is investigating a new type of antibody, which stimulates the immune system to target cancer cells and ...

Two Emerging Infectious Diseases studies link bites from black-legged (deer) and western black-legged ticks to potentially ...

A groundbreaking study has unveiled the microscopic process behind heavy-ion cancer therapy, paving the way for more effective treatment strategies and advancements in radiotherapy technology.

Discover a study that compared the effectiveness of P043 versus omalizumab in managing uncontrolled allergic asthma.

the machine learning immunology company, today announced the presentation of preclinical data for its immunoglobulin E (IgE) protease, S‑8484, demonstrating rapid and sustained degradation of ...

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for ...